Anaerobic isolates in primary pulpal-alveolar cellulitis cases: endodontic resolutions and drug therapy considerations.
D000328:Adult; D000539:Alveolar Process / Q000382:microbiology*; D001421:Bacteria, Anaerobic / Q000302:isolation & purification*; D001431:Bacteriological Techniques; D002481:Cellulitis / Q000382:microbiology* / Q000628:therapy; D002648:Child; D003790:Dental Pulp Necrosis / Q000382:microbiology* / Q000628:therapy; D004917:Erythromycin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010510:Periodontal Diseases / Q000382:microbiology / Q000628:therapy; D012390:Root Canal Therapy
D004917:Erythromycin